We are live on
!
Find out more
Lexeo Therapeutics
LXEO
LXEO
146 hedge funds and large institutions have $759M invested in Lexeo Therapeutics in 2025 Q4 according to their latest regulatory filings, with 47 funds opening new positions, 61 increasing their positions, 26 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
422% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 9
135% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 26
132% more capital invested
Capital invested by funds: $327M → $759M (+$432M)
34% more funds holding
Funds holding: 109 → 146 (+37)
13.42% more ownership
Funds ownership: 91.34% → 104.76% (+13%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less call options, than puts
Call options by funds: $136K | Put options by funds: $143K
Holders
146
Holders Change
+37
Holders Change %
+33.94%
% of All Funds
1.78%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
47
Increased
61
Reduced
26
Closed
9
Calls
$136K
Puts
$143K
Net Calls
-$7K
Net Calls Change
+$77K
Top Buyers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$45.6M |
| 2 |
PBA
Paradigm Biocapital Advisors
New York
|
+$43.5M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
+$30.1M |
| 4 |
BlackRock
New York
|
+$25M |
| 5 |
State Street
Boston,
Massachusetts
|
+$24.1M |
Top Sellers
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
-$20.8M |
| 2 |
Millennium Management
New York
|
-$12.8M |
| 3 |
DCP
D1 Capital Partners
New York
|
-$6.5M |
| 4 |
AAA
Affinity Asset Advisors
New York
|
-$6.12M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$5.44M |
